Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features

Affiliations

• ¹ Rheumatology Unit, Flinders Medical Centre, Adelaide, Australia.
• ² Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia.
• ³ College of Medicine and Public Health, Flinders University, Adelaide, Australia.
• ⁴ Department of Hematology, Hôpital Saint-Louis, Université de Paris, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
• ⁵ Université de Paris, Institut de Recherche Saint-Louis, EMiLy, INSERM U1160, Paris, France.
• ⁶ CNRS, GDR3697 "Microenvironment of tumor niches-Micronit", Paris, France.
• ⁷ Haematology Department, Central Adelaide Local Health Network, Adelaide, Australia.
• ⁸ Blood Cancer, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.
• ⁹ Adelaide Medical School, University of Adelaide, Adelaide, Australia.
• ¹⁰ Department of Medicine, Royal Adelaide Hospital, Adelaide, Australia.
• ¹¹ Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia.
• ¹² Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia.
• ¹³ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
• ¹⁴ Université de Paris, Institut de Recherche Saint-Louis, INSERM U944, Paris, France.
• ¹⁵ Haematology Department, Central Adelaide Local Health Network, Adelaide, Australia. [email protected].
• ¹⁶ Blood Cancer, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia. [email protected].
• ¹⁷ Adelaide Medical School, University of Adelaide, Adelaide, Australia. [email protected].
• ¹⁸ Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia. [email protected].